Diasyst

Medication Intelligence for Chronic Disease Management

  • Stage $1M in TTM Revenue
  • Industry Healthcare Services
  • Location Atlanta, GA, US
  • Currency USD
  • Founded November 2015
  • Employees 25
  • Incorporation Type C-corp
  • Website diasyst.com

Company Summary

Diasyst is at the forefront of transforming how the US delivers healthcare services to chronically ill patients in need. Backed by decades of research at Emory University and the VA, we provide mission-critical software solutions to modernize existing medical practices, while building new clinics to address the critical supply shortage of specialty diabetes providers in the market.

Team

  • Cofounder, Chief Executive Officer

    Georgia Tech biomedical engineer with research background in diabetes and experience in enterprise digital strategy. Leadership in web, mobile, health IT technologies, user experience, product design & development, marketing & branding, sales & operations.

  • Chief Strategy Officer

    Healthcare IT veteran, having helped co-found and build the first enterprise ambulatory practice management system (now NextGen Healthcare, NASDAQ: QSII), servicing over 85,000 providers, employing 4000 people, and generating half a billion in annual revenue.

  • Chief Technology Officer

    Founder of Incept Development, Atlanta-based software agency with a large portfolio of high-quality mobile and webapps; 15+ years of leadership in technical development, computer and information sciences.

  • Cofounder, Clinical Advisor

    Professor of Medicine, Division of Endocrinology, Emory University School of Medicine; Director, Clinical Studies Center, Atlanta VA Medical Center; 40+ years’ experience basic/clinical diabetes care, teaching, and research; 250+ publications; funding from NIH, VA, ADA, pharma; identified “clinical inertia”; leadership in changing provider behavior.

  • Chief Revenue Officer

    Co-founder of FRONTLINE Selling, which helps B2B salespeople and organizations by providing the most effective ways to engage buyers, growing pipelines via predictable, repeatable, and teachable methodologies. Led development of the company's "Staccato" proprietary technology, including the study of 1.8 million outreach efforts, removing the guesswork salespeople go through about who to contact, when, how and how often.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free